construction release_alert

The Scholars Team is working with OIT to resolve some issues with the Scholars search index

cancel

Glioblastoma Immunotherapy Advancement with Nivolumab and Relatlimab

Clinical Trial Grant

Duke Scholars

Principal Investigator Mustafa Khasraw Neurosurgery

Administered By

Duke Cancer Institute

Awarded By

Bristol-Myers Squibb Company

Start Date

November 25, 2024

End Date

June 30, 2029

Administered By

Duke Cancer Institute

Awarded By

Bristol-Myers Squibb Company

Start Date

November 25, 2024

End Date

June 30, 2029